Eli Lilly in advanced talks to buy Kelonia Therapeutics for over $2 billion

Eli Lilly is in advanced talks to buy Kelonia Therapeutics for more than $2 billion as it expands beyond obesity into cancer and gene editing.

Eli Lilly in advanced talks to buy Kelonia Therapeutics for over $2 billion
TAGGED:
Share This Article